Taipei, Taiwan

David Ts Wu

This inventor holds 1 USPTO granted patent. Top assignees: Academia Sinica, Mello Biotech Taiwan Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Ts Wu. Retrieved from https://idiyas.com/inventor/david-ts-wu-20r8az54

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Ts Wu: Innovator in mRNA Technology

Introduction

David Ts Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of mRNA technology for medical applications. His innovative work focuses on creating solutions for viral and cancer treatments.

Latest Patents

David Ts Wu holds a patent for a "Novel mRNA Composition and Production Method for Use in Anti-Viral and Anti-Cancer Vaccines." This patent represents a breakthrough in the development of effective vaccines, showcasing his expertise and commitment to advancing medical science. He has 1 patent to his name.

Career Highlights

Throughout his career, David has worked with notable organizations, including Mello Biotech Taiwan Co., Ltd. and Academia Sinica. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

David has collaborated with talented individuals such as Shi-Lung Lin and Samantha Chang-Lin. These partnerships have enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

David Ts Wu is a key figure in the advancement of mRNA technology, with a focus on developing vaccines for viral and cancer treatments. His contributions to the field are invaluable, and his work continues to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…